Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19

Since December 2019, a novel coronavirus (severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2)) infection has been rapidly spreading worldwide and causing the respiratory illness, coronavirus disease 2019 (COVID‐19). The antiretroviral drug favipiravir (FPV) has been experimentally used for...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Transl Sci
Hlavní autoři: Irie, Kei, Nakagawa, Atsushi, Fujita, Hirotoshi, Tamura, Ryo, Eto, Masaaki, Ikesue, Hiroaki, Muroi, Nobuyuki, Tomii, Keisuke, Hashida, Tohru
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300626/
https://ncbi.nlm.nih.gov/pubmed/32475019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12827
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky